Feasibility Study for Identifying Anti Capsular Antibody Protection Against Invasive Group B Streptococcus (GBS) Disease in Newborns of 0-6 Days Age (Early Onset Disease [EOD]) as Well as Among Infants of 7-90 Days Age (Late Onset Disease [LOD])
NA
The purpose of this study is to evaluate antibody levels against Group B st...
Breakthrough Invasive Mold Infections Under Posaconazole Prophylaxis (BIMI)
N/A
Invasive mold infections (IMI) mainly affect patients with hematologic mali...
Status
Unknown
Location
Medical University of Innsbruck
Start Date
2020-10-01
Trial ID
NCT04720144
Study of Gut Microbiota Diversity in Children Aged 1-3 Years on Prolonged Antibiotic Prophylaxis for Grade 3 or Higher Vesicoureteral Reflux Compared With 2 Age-matched Control Groups
N/A
Urinary tract infections are very common in pediatrics. Urinary antibiotic ...